Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 13(1): 8826, 2023 05 31.
Article in English | MEDLINE | ID: mdl-37258635

ABSTRACT

Multidrug-resistant Pseudomonas aeruginosa (MDRP) is one of the most important pathogens in clinical practice. To clarify the mechanisms contributing to its emergence, we isolated MDRPs using the P. aeruginosa PAO1, the whole genome sequence of which has already been elucidated. Mutant strains resistant to carbapenems, aminoglycosides, and new quinolones, which are used to treat P. aeruginosa infections, were isolated; however, none met the criteria for MDRPs. Then, PAO1 strains were exposed to these antimicrobial agents in various orders and the appearance rate of MDRP varied depending on the order of exposure; MDRPs more frequently appeared when gentamicin was applied before ciprofloxacin, but were rarely isolated when ciprofloxacin was applied first. Exposure to ciprofloxacin followed by gentamicin increased the expression of MexCD-OprJ, an RND-type multidrug efflux pump, due to the NfxB mutation. In contrast, exposure to gentamicin followed by ciprofloxacin resulted in more mutations in DNA gyrase. These results suggest that the type of quinolone resistance mechanism is related to the frequency of MDRP and that the risk of MDRP incidence is highly dependent on the order of exposure to gentamicin and ciprofloxacin.


Subject(s)
Membrane Transport Proteins , Pseudomonas aeruginosa , Membrane Transport Proteins/metabolism , Incidence , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/metabolism , Ciprofloxacin/pharmacology , Ciprofloxacin/metabolism , Gentamicins/pharmacology , Gentamicins/metabolism , Microbial Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...